bax
BAX31.150USD
-0.730-2.29%
종가 05/13, 16:00（ET）시세는 15분 지연됩니다
15.98B시가총액
손실P/E TTM
자세한 내용은 Baxter International Inc 회사
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
회사 정보
회사 코드BAX
회사 이름Baxter International Inc
상장일May 15, 1961
설립일1931
CEOMr. D. Brent Shafer
직원 수38000
유형Ordinary Share
회계 연도 종료May 15
주소One Baxter Parkway
도시DEERFIELD
증권 거래소NYSE Consolidated
국가United States of America
우편 번호60015
전화12249482000
웹사이트https://www.baxter.com/
회사 코드BAX
상장일May 15, 1961
설립일1931
회사 임원
이름
이름/직위
직위
주식 보유
변동
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. Morrison
Ms. Patricia B. Morrison
Independent Director
Independent Director
22.94K
+45.58%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+77.49%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+206.88%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
7.97K
+912.71%
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
지역별USD
이름
수익
비율
United States
5.85B
55.00%
International
4.79B
45.00%
사업별
지역별
사업별USD
이름
수익
비율
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
주주
업데이트 시간: Thu, May 1
업데이트 시간: Thu, May 1
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
11.85%
Dodge & Cox
10.05%
Pzena Investment Management, LLC
7.17%
BlackRock Institutional Trust Company, N.A.
5.90%
State Street Global Advisors (US)
4.25%
Other
60.79%
주주 통계
주주
비율
The Vanguard Group, Inc.
11.85%
Dodge & Cox
10.05%
Pzena Investment Management, LLC
7.17%
BlackRock Institutional Trust Company, N.A.
5.90%
State Street Global Advisors (US)
4.25%
Other
60.79%
유형
주주
비율
Investment Advisor/Hedge Fund
54.52%
Investment Advisor
32.39%
Hedge Fund
2.37%
Pension Fund
2.26%
Research Firm
2.18%
Insurance Company
1.46%
Bank and Trust
1.14%
Sovereign Wealth Fund
1.00%
Individual Investor
0.38%
Other
2.30%
기관 주식 보유
업데이트 시간: Thu, Feb 20
업데이트 시간: Thu, Feb 20
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
1908
505.98M
98.60%
-40.93M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
2023Q1
2123
459.27M
90.86%
-22.24M
2022Q4
2132
456.58M
90.57%
-21.28M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
60.53M
11.8%
+468.84K
+0.78%
Dec 31, 2024
Dodge & Cox
51.58M
10.06%
+1.20M
+2.39%
Feb 28, 2025
Pzena Investment Management, LLC
33.64M
6.56%
+1.42M
+4.39%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
29.53M
5.76%
-652.43K
-2.16%
Dec 31, 2024
State Street Global Advisors (US)
21.79M
4.25%
+12.21K
+0.06%
Dec 31, 2024
BlackRock Financial Management, Inc.
17.57M
3.43%
+1.23M
+7.54%
Dec 31, 2024
T. Rowe Price Associates, Inc.
15.25M
2.97%
+1.13M
+8.03%
Dec 31, 2024
Geode Capital Management, L.L.C.
12.45M
2.43%
+290.28K
+2.39%
Dec 31, 2024
Harris Associates L.P.
8.46M
1.65%
-1.31M
-13.43%
Dec 31, 2024
Columbia Threadneedle Investments (US)
7.28M
1.42%
-2.29M
-23.93%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
Parnassus Value Select ETF
5.03%
Cullen Enhanced Equity Income ETF
4.46%
iShares Large Cap Value Active ETF
2.47%
T Rowe Price Value ETF
2.3%
Global X S&P 500 Quality Dividend ETF
2%
North Shore Equity Rotation ETF
1.94%
iShares U.S. Medical Devices ETF
1.92%
Invesco S&P 500 Equal Weight Health Care ETF
1.54%
SPDR S&P Health Care Equipment ETF
1.52%
First Trust Indxx Medical Devices ETF
1.26%
더 보기
Parnassus Value Select ETF
비율5.03%
Cullen Enhanced Equity Income ETF
비율4.46%
iShares Large Cap Value Active ETF
비율2.47%
T Rowe Price Value ETF
비율2.3%
Global X S&P 500 Quality Dividend ETF
비율2%
North Shore Equity Rotation ETF
비율1.94%
iShares U.S. Medical Devices ETF
비율1.92%
Invesco S&P 500 Equal Weight Health Care ETF
비율1.54%
SPDR S&P Health Care Equipment ETF
비율1.52%
First Trust Indxx Medical Devices ETF
비율1.26%
주식 배당금
지난 5년 동안 총
2.75B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음